Status | Study |
Terminated |
Study Name: Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma Condition: Pancreatic Cancer Date: 2007-12-21 Interventions: Drug: Synthetic Human Secretin 0.2mcg/kg one time dose. |
Completed |
Study Name: Cancer of the Pancreas Screening Study (CAPS 3) Condition: Pancreatic Neoplasm Peutz-Jeghers Syndrome Date: 2007-02-20 Interventions: Procedure: Biopsy, Fine Needle Aspiration (FNA) |
Active, not recruiting |
Study Name: Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer Condition: Familial Ovarian Cancer Familial Breast Cancer BRCA1-assoc Date: 2002-06-22 |
Recruiting |
Study Name: Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex Condition: Cushing's Syndrome Hereditary Neoplastic Syndrome Lentigo Date: 1999-11-03 |